Indefinite Delivery Contract SPE2DB20D9153

This single-award indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through December 31, 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These items are to support the recurring medical supply needs of military health facilities worldwide.

Through this IDC and related delivery orders, DMS Pharmaceutical Group demonstrates its capability to provide a diverse array of pharmaceutical products across multiple categories such as oncology treatments, contraceptives, auto-injectors, and specialized medications. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards. The place of performance for the delivery orders is DMS Pharmaceutical Group's facility in Park Ridge, Illinois.